TW200706538A - Perfluoroalkyl-containing complexes, process for their production as well as their use - Google Patents

Perfluoroalkyl-containing complexes, process for their production as well as their use

Info

Publication number
TW200706538A
TW200706538A TW095125755A TW95125755A TW200706538A TW 200706538 A TW200706538 A TW 200706538A TW 095125755 A TW095125755 A TW 095125755A TW 95125755 A TW95125755 A TW 95125755A TW 200706538 A TW200706538 A TW 200706538A
Authority
TW
Taiwan
Prior art keywords
production
well
perfluoroalkyl
containing complexes
radiodiagnosis
Prior art date
Application number
TW095125755A
Other languages
English (en)
Chinese (zh)
Inventor
Heiko Schirmer
Hanns-Joachim Weinmann
Johannes Platzek
Ludwig Zorn
Bernd Misselwitz
Jorg Meding
Heribert Schmitt-Willich
Thomas Brumby
Original Assignee
Schering Ag
Epix Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag, Epix Pharm Inc filed Critical Schering Ag
Publication of TW200706538A publication Critical patent/TW200706538A/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Radiology & Medical Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
TW095125755A 2005-07-15 2006-07-14 Perfluoroalkyl-containing complexes, process for their production as well as their use TW200706538A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102005033902A DE102005033902B3 (de) 2005-07-15 2005-07-15 Perfluoralkylhaltige Komplexe, Verfahren zu deren Herstellung, sowie deren Verwendung und diese enthaltende pharmazeutische Mittel

Publications (1)

Publication Number Publication Date
TW200706538A true TW200706538A (en) 2007-02-16

Family

ID=37057146

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095125755A TW200706538A (en) 2005-07-15 2006-07-14 Perfluoroalkyl-containing complexes, process for their production as well as their use

Country Status (22)

Country Link
EP (1) EP1904463A2 (de)
JP (1) JP2009501174A (de)
KR (1) KR20080043762A (de)
CN (1) CN101223148A (de)
AR (1) AR054865A1 (de)
AU (1) AU2006272025A1 (de)
BR (1) BRPI0613407A2 (de)
CA (1) CA2615443A1 (de)
CR (1) CR9645A (de)
DE (1) DE102005033902B3 (de)
DO (1) DOP2006000167A (de)
EC (1) ECSP088100A (de)
GT (1) GT200600313A (de)
IL (1) IL187926A0 (de)
NO (1) NO20080813L (de)
PE (1) PE20070376A1 (de)
RU (1) RU2008105356A (de)
TN (1) TNSN08016A1 (de)
TW (1) TW200706538A (de)
UY (1) UY29664A1 (de)
WO (1) WO2007009638A2 (de)
ZA (1) ZA200801523B (de)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102007015598A1 (de) * 2007-03-29 2008-10-02 Heinrich-Heine-Universität Düsseldorf Verwendung von fluorhaltigen Verbindungen zu Diagnosezwecken mit Hilfe bildgebender Verfahren
US8361438B2 (en) 2008-01-08 2013-01-29 Lantheus Medical Imaging, Inc. N-alkoxyamide conjugates as imaging agents
EP4037691A4 (de) * 2019-10-04 2023-11-22 United States Government as Represented by The Department of Veterans Affairs Entwicklung von bildgebenden und therapeutischen glukoseanaloga für natrium-abhängige glukosetransporter
EP4059925A1 (de) 2021-03-15 2022-09-21 Bayer Aktiengesellschaft Neues kontrastmittel zur verwendung in der magnetresonanzbildgebung
CN114181164A (zh) * 2021-12-13 2022-03-15 武汉大学中南医院 基于Fe(Ⅱ)特异性MRI对比剂的合成方法及其应用
EP4335840A1 (de) 2022-09-09 2024-03-13 Bayer Aktiengesellschaft Neue kontrastmittel zur verwendung in der diagnostischen bildgebung
EP4335462A1 (de) 2022-09-09 2024-03-13 Bayer AG Kontrastmittel zur verwendung in der diagnostischen bildgebung mittels computertomografie

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4317588C2 (de) * 1993-05-24 1998-04-16 Schering Ag Fluorhaltige makrocyclische Metallkomplexe, Verfahren zu ihrer Herstellung, sowie ihre Verwendung
DE19603033A1 (de) * 1996-01-19 1997-07-24 Schering Ag Perfluoralkylhaltige Metallkomplexe, Verfahren zu deren Herstellung und ihre Verwendung in der NMR-Diagnostik
DE19744004C1 (de) * 1997-09-26 1999-07-22 Schering Ag Lipophile Metall-Komplexe für Nekrose und Infarkt-Imaging
DE19744003B4 (de) * 1997-09-26 2004-07-08 Schering Ag Kontrastmittel für das Infarkt- und Nekroseimaging
DE19914101C1 (de) * 1999-03-22 2000-10-12 Schering Ag Perfluoralkylamide, ihre Herstellung und ihre Verwendung in der Diagnostik
DE10040858C2 (de) * 2000-08-11 2003-12-18 Schering Ag Perfluoralkylhaltige Komplexe mit polaren Resten, Verfahren zu deren Herstellung und ihre Verwendung

Also Published As

Publication number Publication date
JP2009501174A (ja) 2009-01-15
AU2006272025A1 (en) 2007-01-25
DOP2006000167A (es) 2007-02-28
EP1904463A2 (de) 2008-04-02
NO20080813L (no) 2008-04-09
CR9645A (es) 2008-05-21
TNSN08016A1 (en) 2009-07-14
KR20080043762A (ko) 2008-05-19
PE20070376A1 (es) 2007-04-20
RU2008105356A (ru) 2009-08-20
UY29664A1 (es) 2007-02-28
IL187926A0 (en) 2008-03-20
WO2007009638A2 (de) 2007-01-25
BRPI0613407A2 (pt) 2011-01-11
WO2007009638A3 (de) 2007-04-26
CN101223148A (zh) 2008-07-16
CA2615443A1 (en) 2007-01-25
ZA200801523B (en) 2008-11-26
AR054865A1 (es) 2007-07-25
GT200600313A (es) 2007-04-23
ECSP088100A (es) 2008-05-30
DE102005033902B3 (de) 2007-04-05

Similar Documents

Publication Publication Date Title
MX2009012950A (es) ANTICUERPOS HUMANIZADOS CONTRA EL GLOBULOMERO Aß (20-42) Y SUS USOS.
MX2009012949A (es) Anticuerpos humanizados que enlazan a ab (1-42) globulomero y usos de los mismos.
TN2009000063A1 (en) Compounds and methods for 18f labeled agents
TW200740777A (en) Perfluoroalkyl-containing complexes, process for their production as well as their use
ZA200701280B (en) MR imaging method for the discrimination between healthy and tumour tissue
WO2011045415A3 (en) Imaging agents and their use for the diagnostic in vivo of neurodegenerative diseases, notably alzheimer's disease and derivative diseases
MY153198A (en) Inhibitors of protein aggregation
MX2010005022A (es) Anticuerpos que unen celulas dendriticas y epiteliales 205 (dec-205) humanas.
MX2012007041A (es) Quelados de manganeso y su uso como agentes de contraste en elaboracion de imagen de resonancia magnetica (mri).
MY157365A (en) Chemical compounds and uses
MX2009012625A (es) Metodos para el tratamiento, diagnostico y deteccion de trastornos asociados con el fgf21.
WO2007016548A3 (en) Micro-rna-based methods and compositions for the diagnosis, prognosis and treatment of breast cancer
MX2010003368A (es) Derivados de imidazol.
MX2007001035A (es) Metodo para producir una composicion, la composicion y su uso.
WO2007002109A3 (en) Multidentate pyrone-derived chelators for medicinal imaging and chelation
ZA201802846B (en) Dimeric contrast agents
MX2009004435A (es) Tinturas dispersas, su preparacion y su uso.
WO2012065045A3 (en) Development and screening of contrast agents for in vivo imagining of parkinson's disease
MX357227B (es) Nanoparticulas basadas en lipidos.
NO20080813L (no) Komplekser inneholdende perfluoralkyl, fremgangsmate for fremstilling og anvendelse derav
EP3441467A3 (de) Biotinkomplexe zur behandlung und diagnose von morbus alzheimer
WO2008008786A3 (en) Pre- and intra- operative imaging of bladder cancer
MY155340A (en) Use of cathepsin c
MY148553A (en) Metal chelates having a perfluorinated peg radical, processes for their preparation, and their use
IL218456A (en) Diagnostic Composition Containing Bite History (2,4,6 - Triodophenyl) and Methods for Diagnosis and Imaging